Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Non-migrating cells from the upper chamber were wiped away with a cotton swab
Study participants We identified all adult (aged 20 years) patients with NAFLD and type 2 diabetes who had newly started treatment with non-insulin glucose-lowering drugs (metformin, GLP-1RAs, SGLT2 inhibitors, sulfonylureas, meglitinides, thiazolidinediones, acarbose or dipeptidyl peptidase-4 inhibitors) between 1 January 2013 and 31 December 2021
White Distinguished Professor in the department of pharmacotherapy at Washington State University (WSU) College of Pharmacy and Pharmaceutical Sciences, and the ADAs president of health care and education, and colleagues wrote in the ADA statement
10.1023/A:1005437616934
US$ 20.65
US$ 24.14
US$ 29.21
US$ 25.64
US$ 21.86
US$ 21.91
US$ 26.15
US$ 23.36
